l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with ceruletide in 1 studies
| Studies (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Trials (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Recent Studies (post-2010) (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Studies (ceruletide) | Trials (ceruletide) | Recent Studies (post-2010) (ceruletide) |
|---|---|---|---|---|---|
| 138 | 7 | 2 | 3,002 | 91 | 645 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, M; Haneda, M; Hiraishi, H; Nakamura, K; Shimada, T; Terano, A; Yoneda, M | 1 |
1 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and ceruletide
| Article | Year |
|---|---|
Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats.
Topics: Adrenergic Agents; Amylases; Animals; Central Nervous System; Ceruletide; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Male; Neuropeptides; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidopamine; Pancreas; Pancreatitis; Peptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Thyrotropin-Releasing Hormone; Time Factors | 2005 |